Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 4, 6, and 12–14 months of age.
Vaccine , 2011;29:1324–1331. doi: 10.1016/j.vaccine.2010.11.053